Woodline Partners LP Ardelyx, Inc. Transaction History

Woodline Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$3.3 - $4.83 $6.93 Million - $10.1 Million	-2,099,437 Reduced 87.74%	293,425 $1.2 Million
Q2 2023 Aug 14, 2023	BUY	$3.23 - $4.95 $4.61 Million - $7.07 Million	1,427,863 Added 147.97%	2,392,862 $8.11 Million
Q1 2023 May 15, 2023	SELL	$2.68 - $4.79 $6.73 Million - $12 Million	-2,510,961 Reduced 72.24%	964,999 $4.62 Million
Q4 2022 Feb 14, 2023	SELL	$1.22 - $2.85 $2.27 Million - $5.31 Million	-1,863,105 Reduced 34.9%	3,475,960 $9.91 Million
Q3 2022 Nov 14, 2022	BUY	$0.59 - $1.44 $3.15 Million - $7.69 Million	5,339,065 New	5,339,065 $6.35 Million

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.